These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6145679)

  • 1. Comparison of the reinforcing properties of zopiclone and triazolam in former alcoholics.
    Bechelli LP; Navas F; Pierangelo SA
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():235-41. PubMed ID: 6145679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the reinforcing properties of zopiclone and triazolam in former alcoholics.
    Bechelli LP; Navas F; Pierangelo SA
    Pharmacology; 1983; 27 Suppl 2():235-41. PubMed ID: 6142466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the dependence-inducing potential of zopiclone and triazolam.
    Boissl K; Dreyfus JF; Delmotte M
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():242-7. PubMed ID: 6145680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the dependence-inducing potential of zopiclone and triazolam.
    Boissl K; Dreyfus JF; Delmotte M
    Pharmacology; 1983; 27 Suppl 2():242-7. PubMed ID: 6142467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
    Fleming JA; McClure DJ; Mayes C; Phillips R; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():29-37. PubMed ID: 2201728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
    Mouret J; Ruel D; Maillard F; Bianchi M
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():47-55. PubMed ID: 2201730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adverse effects of zopiclone].
    Bramness JG; Olsen H
    Tidsskr Nor Laegeforen; 1998 May; 118(13):2029-32. PubMed ID: 9656789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs.
    Elie R; Frenay M; Le Morvan P; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():39-46. PubMed ID: 2201729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of zopiclone physical dependence liability in normal volunteers.
    Dorian P; Sellers EM; Kaplan H; Hamilton C
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():228-34. PubMed ID: 7188376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of zopiclone and triazolam in patients with insomnia.
    Chaudoir PJ; Bodkin NL; O'Donnell J; Anderson A; Holland RL
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():21-7. PubMed ID: 2201727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
    Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):117-23. PubMed ID: 11697572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effects of zopiclone and triazolam on the sleep of normal subjects].
    Tiberge M; Calvet U; Khayi N; Delahaye C; Arbus L
    Encephale; 1988; 14(4):319-24. PubMed ID: 3058455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical hypnotic effects of zopiclone and triazolam.
    Autret E; Maillard F; Autret A
    Eur J Clin Pharmacol; 1987; 31(5):621-3. PubMed ID: 3549323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of short-action hypnotics triazolam and zopiclone on simulated flight performance].
    Jing BS; Zhan H; Li YF; Zhou YJ; Guo H
    Space Med Med Eng (Beijing); 2003 Oct; 16(5):329-31. PubMed ID: 14753231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers.
    Lader M; Denney SC
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():98-108. PubMed ID: 7188379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective effects during administration and on discontinuation of zopiclone and temazepam in normal subjects.
    Lader M; Frcka G
    Pharmacopsychiatry; 1987 Mar; 20(2):67-71. PubMed ID: 2884682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misuse of zopiclone and convulsions during withdrawal.
    Aranko K; Henriksson M; Hublin C; Seppäläinen AM
    Pharmacopsychiatry; 1991 Jul; 24(4):138-40. PubMed ID: 1754610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
    Bliwise DL; Seidel WF; Cohen SA; Bliwise NG; Dement WC
    J Clin Psychiatry; 1988 Sep; 49(9):349-55. PubMed ID: 3047100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety.
    Fontaine R; Beaudry P; Le Morvan P; Beauclair L; Chouinard G
    Int Clin Psychopharmacol; 1990 Jul; 5(3):173-83. PubMed ID: 2230061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena.
    Bianchi M; Musch B
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():139-45. PubMed ID: 2387981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.